Juvenescence is a biotech company that develops therapies and products to modify aging and help people live longer.
Juvenescence has raised $76.0M in total funding. The most recent round was Series B. The last funding was announced in April 2025.
Juvenescence's investors include Foresite Capital, Longevity Vision Fund, Apeiron Investment Group, Kingsley Advani, M42.
Juvenescence is headquartered in Dublin, Ireland.
Juvenescence is a biotech company that develops therapies and products to modify aging and help people live longer.
Juvenescence is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Juvenescence — Funding & Investors." VCBacked, April 16, 2025, https://www.vcbacked.co/company/juvenescence. Accessed November 12, 2026.
VCBacked. (2025). Juvenescence — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/juvenescence
{{cite web |title=Juvenescence — Funding & Investors |url=https://www.vcbacked.co/company/juvenescence |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Juvenescence? Request a listing update